Impact of the Pro12Ala polymorphism of the PPAR-gamma2 gene on serum triacylglycerol response to n-3 fatty acid supplementation.
about
Personalized nutrition and cardiovascular disease prevention: From Framingham to PREDIMEDEffects on metabolic markers are modified by PPARG2 and COX2 polymorphisms in infants randomized to fish oilGenome-wide association study of the plasma triglyceride response to an n-3 polyunsaturated fatty acid supplementation.PPAR gamma and human metabolic diseasePlasma Triglyceride Levels May Be Modulated by Gene Expression of IQCJ, NXPH1, PHF17 and MYB in HumansInteraction of PPARG Pro12Ala with dietary fat influences plasma lipids in subjects at cardiometabolic risk.Interactions between dietary n-3 fatty acids and genetic variants and risk of diseaseDiet, genetics, and disease: a focus on the middle East and north Africa region.Nutrigenetics and CVD: what does the future hold?The integration of epigenetics and genetics in nutrition research for CVD risk factors.Regulation of tissue LC-PUFA contents, Δ6 fatty acyl desaturase (FADS2) gene expression and the methylation of the putative FADS2 gene promoter by different dietary fatty acid profiles in Japanese seabass (Lateolabrax japonicus).Association between erythrocyte membrane fatty acids and biomarkers of dyslipidemia in the EPIC-Potsdam study.Nutrigenetics: a tool to provide personalized nutritional therapy to the obese.Replication of a Gene-Diet Interaction at CD36, NOS3 and PPARG in Response to Omega-3 Fatty Acid Supplements on Blood Lipids: A Double-Blind Randomized Controlled Trial.Interaction between diets, polymorphisms and plasma lipid levelsErythrocyte membrane phospholipid polyunsaturated fatty acids are related to plasma C-reactive protein and adiponectin in middle-aged German women and men
P2860
Q33578732-506BA52A-F387-4FAC-B791-6B2AC1EFCA62Q33632873-9B4F051F-1347-4D72-801C-CC5F8BD56DEAQ33825102-B39D569D-129B-4C29-913E-4D6284576F0EQ34416432-DD3D43BA-D9CE-4C50-84CD-1C0A6B7A8A46Q34680636-41D3AFE2-A9AF-49FD-8B84-181B47553794Q35561993-0560EA88-DB29-43D4-BC94-7CD107C7BB03Q35598019-1B10177D-8839-441E-9629-4EFB3F8EE638Q35875735-C4508687-4BBE-4208-B763-FDA4A1B49BD6Q37138663-0ABDA233-73A9-46F6-81D0-82220363B2FFQ39029674-4B242B93-5E7C-4CA6-B101-96DB6190C7A6Q41904544-5DBAA212-0298-4506-98D8-80213C67505CQ53064901-AAAB7809-7E33-45A6-8B06-B1B4D91CFA5BQ54012778-7F527716-433E-4877-B22A-9DA947237C9CQ55339935-AF272251-1B99-4A8A-815F-5EA7303E0D44Q57316305-EA409C9F-F2B5-41AE-B50E-307D0CE5065FQ57659526-DCC9C96D-2A9F-4D42-A408-C5B3532F7F65
P2860
Impact of the Pro12Ala polymorphism of the PPAR-gamma2 gene on serum triacylglycerol response to n-3 fatty acid supplementation.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Impact of the Pro12Ala polymor ...... -3 fatty acid supplementation.
@en
Impact of the Pro12Ala polymor ...... -3 fatty acid supplementation.
@nl
type
label
Impact of the Pro12Ala polymor ...... -3 fatty acid supplementation.
@en
Impact of the Pro12Ala polymor ...... -3 fatty acid supplementation.
@nl
prefLabel
Impact of the Pro12Ala polymor ...... -3 fatty acid supplementation.
@en
Impact of the Pro12Ala polymor ...... -3 fatty acid supplementation.
@nl
P2093
P1476
Impact of the Pro12Ala polymor ...... -3 fatty acid supplementation.
@en
P2093
Angela A Rivellese
Anne Louheranta
Bengt Vessby
Gabriele Riccardi
KANWU Study Group
Kjeld Hermansen
Len Storlien
Ursula Schwab
P356
10.1016/S1096-7192(03)00065-9
P577
2003-05-01T00:00:00Z